Thermo Fisher Scientific Inc (NYSE:TMO) Stake Reduced by APG Asset Management N.V.

APG Asset Management N.V. lowered its stake in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 54.4% during the second quarter, according to its most recent filing with the SEC. The fund owned 122,179 shares of the medical research company’s stock after selling 145,848 shares during the period. APG Asset Management N.V.’s holdings in Thermo Fisher Scientific were worth $21,317,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Gulf International Bank UK Ltd boosted its stake in shares of Thermo Fisher Scientific by 2.1% in the first quarter. Gulf International Bank UK Ltd now owns 122,961 shares of the medical research company’s stock valued at $18,886,000 after buying an additional 2,500 shares during the period. Quadrant Capital Group LLC boosted its stake in shares of Thermo Fisher Scientific by 3.7% in the first quarter. Quadrant Capital Group LLC now owns 2,913 shares of the medical research company’s stock valued at $439,000 after buying an additional 104 shares during the period. Newman Dignan & Sheerar Inc. boosted its stake in shares of Thermo Fisher Scientific by 2.2% in the first quarter. Newman Dignan & Sheerar Inc. now owns 3,688 shares of the medical research company’s stock valued at $566,000 after buying an additional 80 shares during the period. Country Club Trust Company n.a. raised its stake in shares of Thermo Fisher Scientific by 4.9% in the first quarter. Country Club Trust Company n.a. now owns 40,390 shares of the medical research company’s stock valued at $6,204,000 after buying an additional 1,894 shares in the last quarter. Finally, National Pension Service raised its stake in shares of Thermo Fisher Scientific by 1.3% in the first quarter. National Pension Service now owns 282,001 shares of the medical research company’s stock valued at $43,403,000 after buying an additional 3,599 shares in the last quarter. 87.60% of the stock is currently owned by institutional investors and hedge funds.

Shares of Thermo Fisher Scientific Inc (TMO) traded down 0.19% during midday trading on Friday, reaching $172.57. The company’s stock had a trading volume of 1,182,702 shares. The company has a 50 day moving average of $176.71 and a 200-day moving average of $166.56. Thermo Fisher Scientific Inc has a 52 week low of $139.07 and a 52 week high of $182.87. The stock has a market capitalization of $67.32 billion, a price-to-earnings ratio of 30.06 and a beta of 1.06.

Thermo Fisher Scientific (NYSE:TMO) last announced its earnings results on Wednesday, July 26th. The medical research company reported $2.30 EPS for the quarter, beating analysts’ consensus estimates of $2.27 by $0.03. Thermo Fisher Scientific had a net margin of 11.80% and a return on equity of 15.97%. The business had revenue of $5 billion during the quarter, compared to analysts’ expectations of $4.92 billion. During the same period in the prior year, the company earned $2.03 earnings per share. The business’s revenue was up 10.2% compared to the same quarter last year. Equities research analysts predict that Thermo Fisher Scientific Inc will post $9.24 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, October 16th. Stockholders of record on Friday, September 15th will be issued a $0.15 dividend. The ex-dividend date is Thursday, September 14th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.35%. Thermo Fisher Scientific’s payout ratio is 10.45%.

ILLEGAL ACTIVITY NOTICE: “Thermo Fisher Scientific Inc (NYSE:TMO) Stake Reduced by APG Asset Management N.V.” was first posted by Community Financial News and is the property of of Community Financial News. If you are viewing this report on another publication, it was stolen and reposted in violation of international trademark & copyright law. The correct version of this report can be read at https://www.com-unik.info/2017/08/19/apg-asset-management-n-v-has-21-32-million-position-in-thermo-fisher-scientific-inc-nysetmo-updated.html.

Several analysts have recently commented on the company. Bank of America Corporation increased their price objective on Thermo Fisher Scientific from $190.00 to $200.00 and gave the company a “buy” rating in a report on Tuesday, May 9th. Cleveland Research upgraded Thermo Fisher Scientific from a “neutral” rating to a “buy” rating in a report on Thursday, July 20th. Jefferies Group LLC increased their price objective on Thermo Fisher Scientific from $160.00 to $175.00 and gave the company a “hold” rating in a report on Friday, April 28th. BidaskClub lowered Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a report on Tuesday, June 27th. Finally, Citigroup Inc. reiterated a “buy” rating and set a $201.00 price objective (up previously from $182.00) on shares of Thermo Fisher Scientific in a report on Monday, July 10th. One research analyst has rated the stock with a hold rating, sixteen have given a buy rating and one has assigned a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $188.56.

In related news, Director Jim P. Manzi sold 11,318 shares of the stock in a transaction dated Friday, August 18th. The shares were sold at an average price of $172.94, for a total transaction of $1,957,334.92. Following the completion of the transaction, the director now directly owns 38,757 shares of the company’s stock, valued at $6,702,635.58. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Daniel P. Shine sold 4,688 shares of the stock in a transaction dated Wednesday, May 24th. The stock was sold at an average price of $171.88, for a total transaction of $805,773.44. Following the transaction, the insider now directly owns 29,200 shares of the company’s stock, valued at $5,018,896. The disclosure for this sale can be found here. Insiders have sold 39,506 shares of company stock valued at $6,834,758 over the last three months. 0.49% of the stock is currently owned by corporate insiders.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

What are top analysts saying about Thermo Fisher Scientific Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Thermo Fisher Scientific Inc and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit